
QIPT
Quipt Home Medical Corp
- Overview
- Forecast
- Valuation
- Earnings

Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
2.245
Open
2.230
VWAP
2.20
Vol
206.63K
Mkt Cap
95.14M
Low
2.180
Amount
455.53K
EV/EBITDA(TTM)
4.19
Total Shares
42.57M
EV
182.69M
EV/OCF(TTM)
5.54
P/S(TTM)
0.39
Quipt Home Medical Corp. is a home medical equipment provider. The Company provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. The Company’s comprehensive solutions support patients dealing with heart and pulmonary diseases, sleep apnea, reduced mobility, and other chronic health challenges. The Company serves patients approximately 26 states in the United States. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, home medical equipment, and custom mobility solutions.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q1
FY2025Q4
FY2025Q3
59.04M
-3.88%
--
--
58.16M
-5.06%
--
--
57.51M
-9.99%
--
--
Estimates Revision
The market is revising Upward the revenue expectations for Quipt Home Medical Corp. (QIPT) for FY2025, with the revenue forecasts being adjusted by 1.78% over the past three months. During the same period, the stock price has changed by 4.29%.
Revenue Estimates for FY2025
Revise Upward

+1.78%
In Past 3 Month
Stock Price
Go Up

+4.29%
In Past 3 Month
3 Analyst Rating

61.64% Upside
Wall Street analysts forecast QIPT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for QIPT is 3.54 USD with a low forecast of 1.70 USD and a high forecast of 4.93 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
1 Hold
0 Sell
Moderate Buy

61.64% Upside
Current: 2.190

Low
1.70
Averages
3.54
High
4.93

61.64% Upside
Current: 2.190

Low
1.70
Averages
3.54
High
4.93
Canaccord
Richard Close
Buy
to
Hold
downgrade
$4
2025-05-14
Reason
Canaccord
Richard Close
Price Target
$4
2025-05-14
downgrade
Buy
to
Hold
Reason
Bill Sutherland
Buy
downgrade
$6 -> $4
2025-05-14
Reason
Bill Sutherland
Price Target
$6 -> $4
2025-05-14
downgrade
Buy
Reason
Benchmark analyst Bill Sutherland lowered the firm's price target on Quipt Home Medical to $4 from $6 and keeps a Buy rating on the shares after revenue missed expectations in fiscal Q2. On a positive note, Quipt continues to see no negative impact from GLP-1 medications on demand for sleep therapy set ups and supplies, like other respiratory-focused home medical equipment companies, the analyst noted.
Canaccord
Buy
to
Hold
downgrade
$4
2025-05-13
Reason
Canaccord
Price Target
$4
2025-05-13
downgrade
Buy
to
Hold
Reason
Canaccord downgraded Quipt Home Medical to Hold from Buy with a price target of $1.70, down from $4.
Benchmark
Bill Sutherland
Strong Buy
Maintains
$9 → $7
2024-08-21
Reason
Benchmark
Bill Sutherland
Price Target
$9 → $7
2024-08-21
Maintains
Strong Buy
Reason
Canaccord Genuity
Richard Close
Strong Buy
Maintains
$8 → $6
2024-08-16
Reason
Canaccord Genuity
Richard Close
Price Target
$8 → $6
2024-08-16
Maintains
Strong Buy
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Quipt Home Medical Corp (QIPT.O) is -9.33, compared to its 5-year average forward P/E of 4.43. For a more detailed relative valuation and DCF analysis to assess Quipt Home Medical Corp 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A
5Y Average PE
4.43
Current PE
-9.33
Overvalued PE
131.05
Undervalued PE
-122.19
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Undervalued
5Y Average EV/EBITDA
4.83
Current EV/EBITDA
3.36
Overvalued EV/EBITDA
6.26
Undervalued EV/EBITDA
3.41
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Undervalued
5Y Average PS
0.93
Current PS
0.41
Overvalued PS
1.35
Undervalued PS
0.51
Financials
Annual
Quarterly
FY2025Q1
YoY :
-1.90%
61.38M
Total Revenue
FY2025Q1
YoY :
-61.77%
479.00K
Operating Profit
FY2025Q1
YoY :
-27.15%
-1.08M
Net Income after Tax
FY2025Q1
YoY :
-25.00%
-0.03
EPS - Diluted
FY2025Q1
YoY :
-37.81%
5.62M
Free Cash Flow
FY2025Q1
YoY :
-0.75%
53.14
Gross Profit Margin - %
FY2025Q1
YoY :
-25.63%
-1.77
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
1
41.6K
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
1
246.5K
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
1
41.6K
USD
Months
0-12
0
0.0
USD
Months
QIPT News & Events
Events Timeline
2025-07-07 (ET)
2025-07-07
07:37:38
Quipt Home Medical acquires full-service durable medical equipment provider

2025-06-04 (ET)
2025-06-04
08:45:05
Forager requests Quipt Home Medical terminate standstill agreement

2025-05-21 (ET)
2025-05-21
07:32:21
Quipt Home Medical confirms receipt of unsolicited acquisition proposal

Sign Up For More Events
Sign Up For More Events
News
7.0
07-12PRnewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Quipt Home Medical Corp. - QIPT
7.0
07-07PRnewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Quipt Home Medical Corp. - QIPT
8.5
07-07SeekingAlphaQuipt Home Medical acquires medical equipment provider owned by Ballad Health
Sign Up For More News
People Also Watch

EUDA
EUDA Health Holdings Ltd
3.120
USD
+0.97%

GATE
Marblegate Acquisition Corp
36.050
USD
+45.60%

ZOM
Zomedica Corp
0.097
USD
0.00%

DTI
Drilling Tools International Corp
2.280
USD
-1.30%

MNSB
MainStreet Bancshares Inc
21.300
USD
-1.66%

VGAS
Verde Clean Fuels Inc
3.190
USD
-1.24%

ULBI
Ultralife Corp
8.750
USD
-2.78%

HURC
Hurco Companies Inc
19.760
USD
+2.70%

LCTX
Lineage Cell Therapeutics Inc
1.150
USD
+6.48%

OPOF
Old Point Financial Corp
41.290
USD
-0.17%
FAQ

What is Quipt Home Medical Corp (QIPT) stock price today?
The current price of QIPT is 2.19 USD — it has decreased -2.23 % in the last trading day.

What is Quipt Home Medical Corp (QIPT)'s business?

What is the price predicton of QIPT Stock?

What is Quipt Home Medical Corp (QIPT)'s revenue for the last quarter?

What is Quipt Home Medical Corp (QIPT)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Quipt Home Medical Corp (QIPT)'s fundamentals?

How many employees does Quipt Home Medical Corp (QIPT). have?
